Battelle   Report issue

For profit Phase 1
Founded: Columbus OH United States (1923)
Status: No NME R&D (1923)

Organization Overview

First Clinical Trial
2017
NCT02961309
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Battelle | Battelle Memorial Institute

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcohol Drinking (Phase 1)

Alcoholism (Phase 1)

Alphavirus Infections (Phase 1)

Encephalitis (Phase 1)

Encephalomyelitis, Eastern Equine (Phase 1)

Encephalomyelitis, Equine (Phase 1)

Encephalomyelitis, Venezuelan Equine (Phase 1)

Encephalomyelitis, Western Equine (Phase 1)

Marijuana Abuse (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 7
  • # of Trial APIs: 6